Preliminary data show a difference in intra-tumoral cytokine profiles in such animals, and a difference in phenotype of cells infiltrating the re-challenged EMT6 tumor in WT mice compared with those infiltrating a primary tumor challenge, with increased CD4+ cells. This evidence concerns the gene CD4 and neoplasm.